Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
G1 Therapeutics Inc (GTHX)
NASDAQ:GTHX
G1 Therapeutics (GTHX) Stock Price & Analysis
1,821 Followers
GTHX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.08 - $5.00
Previous Close$4.78
Volume1.06M
Average Volume (3M)1.42M
Market Cap
$249.51M
Enterprise Value$211.08M
Total Cash (Recent Filing)$94.35M
Total Debt (Recent Filing)$55.92M
Price to Earnings (P/E)-5.0
Beta1.92
Next Earnings
May 01, 2024EPS Estimate
-$0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.95
Shares Outstanding52,199,394
10 Day Avg. Volume1,034,015
30 Day Avg. Volume1,417,136
Standard Deviation0.29
R-Squared0.10
Alpha-0.00298
Financial Highlights & Ratios
Price to Book (P/B)7.05
Price to Sales (P/S)4.86
Price to Cash Flow (P/CF)-4.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.71
Enterprise Value/Gross Profit4.11
Enterprise Value/Ebitda-6.02
Forecast
1Y Price Target
$8.33Price Target Upside74.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
G1 Therapeutics News
Ownership Overview
22.79% Insiders
9.58% Mutual Funds
7.68% Other Institutional Investors
59.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GTHX FAQ
What was G1 Therapeutics Inc’s price range in the past 12 months?
G1 Therapeutics Inc lowest stock price was $1.08 and its highest was $5.00 in the past 12 months.
What is G1 Therapeutics Inc’s market cap?
Currently, no data Available
When is G1 Therapeutics Inc’s upcoming earnings report date?
G1 Therapeutics Inc’s upcoming earnings report date is May 01, 2024 which is in 15 days.
How were G1 Therapeutics Inc’s earnings last quarter?
G1 Therapeutics Inc released its earnings results on Feb 28, 2024. The company reported -$0.21 earnings per share for the quarter, beating the consensus estimate of -$0.278 by $0.068.
Is G1 Therapeutics Inc overvalued?
According to Wall Street analysts G1 Therapeutics Inc’s price is currently Undervalued.
Does G1 Therapeutics Inc pay dividends?
G1 Therapeutics Inc does not currently pay dividends.
What is G1 Therapeutics Inc’s EPS estimate?
G1 Therapeutics Inc’s EPS estimate is -$0.2.
How many shares outstanding does G1 Therapeutics Inc have?
G1 Therapeutics Inc has 52,199,394 shares outstanding.
What happened to G1 Therapeutics Inc’s price movement after its last earnings report?
G1 Therapeutics Inc reported an EPS of -$0.21 in its last earnings report, beating expectations of -$0.278. Following the earnings report the stock price went up 38.75%.
Which hedge fund is a major shareholder of G1 Therapeutics Inc?
Among the largest hedge funds holding G1 Therapeutics Inc’s share is Fisher Asset Management LLC. It holds G1 Therapeutics Inc’s shares valued at N/A.
---
G1 Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.33 (74.63% Upside)
$8.33 (74.63% Upside)
Blogger Sentiment
Bullish
GTHX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 2.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $101.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 2.2%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
91.96%
12-Months-Change
Fundamentals
Return on Equity
-92.13%
Trailing 12-Months
Asset Growth
-35.34%
Trailing 12-Months
Company Description
G1 Therapeutics Inc
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
---
GTHX Earnings Call
Q4 2024
0:00 / 0:00
---
GTHX Stock 12 Months Forecast
Average Price Target
$8.33
▲(74.63% Upside)
Technical Analysis
Best Analysts Covering GTHX
1 Year
1 Year Success Rate
8/20 ratings generated profit
1 Year Average Return
-22.79%
reiterated a buy rating 12 months ago
Copying Dane Leone's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -22.79% per trade.
---